- Home
- ARWR vs CRGY Comparison
ARWR vs CRGY Comparison
Compare ARWR & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- CRGY
- Stock Information
- Founded
- ARWR 2003
- CRGY 1986
- Country
- ARWR United States
- CRGY United States
- Employees
- ARWR N/A
- CRGY N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- CRGY Oil & Gas Production
- Sector
- ARWR Health Care
- CRGY Energy
- Exchange
- ARWR Nasdaq
- CRGY Nasdaq
- Market Cap
- ARWR 1.8B
- CRGY 2.1B
- IPO Year
- ARWR 1993
- CRGY N/A
- Fundamental
- Price
- ARWR $13.07
- CRGY $8.43
- Analyst Decision
- ARWR Buy
- CRGY Buy
- Analyst Count
- ARWR 11
- CRGY 11
- Target Price
- ARWR $41.44
- CRGY $17.33
- AVG Volume (30 Days)
- ARWR 1.7M
- CRGY 4.1M
- Earning Date
- ARWR 05-12-2025
- CRGY 05-05-2025
- Dividend Yield
- ARWR N/A
- CRGY 5.74%
- EPS Growth
- ARWR N/A
- CRGY N/A
- EPS
- ARWR N/A
- CRGY N/A
- Revenue
- ARWR $2,500,000.00
- CRGY $3,223,618,000.00
- Revenue This Year
- ARWR $4,380.43
- CRGY $29.75
- Revenue Next Year
- ARWR $64.24
- CRGY N/A
- P/E Ratio
- ARWR N/A
- CRGY N/A
- Revenue Growth
- ARWR N/A
- CRGY 31.58
- 52 Week Low
- ARWR $9.57
- CRGY $6.83
- 52 Week High
- ARWR $30.41
- CRGY $16.94
- Technical
- Relative Strength Index (RSI)
- ARWR 53.31
- CRGY 45.29
- Support Level
- ARWR $12.44
- CRGY $7.71
- Resistance Level
- ARWR $14.97
- CRGY $8.75
- Average True Range (ATR)
- ARWR 0.71
- CRGY 0.33
- MACD
- ARWR 0.16
- CRGY 0.13
- Stochastic Oscillator
- ARWR 61.36
- CRGY 65.35
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.